We measured the histologic stromal and epithelial tissue components of the benign (normal) and malignant tissue compartments of Japanese-Americans (J-A) and native Japanese (NJ) men living in Japan. The patient cohort included 25 NJ men undergoing radical prostatectomy (RP) in Nagoya, Japan and 25 J-A (second or third generation US born). We conducted tissue image quantitation (in-house image software) of the stromal and epithelial compartments in malignant and adjacent normal tissue areas from a tissue microarray (TMA) selected from radical prostatectomy (RP) blocks. Stromal-epithelial (S-E) areas were determined using immunohistochemical stains for CAM-5.2 epithelial cytokeratin marker and the Masson trichrome stain to measure the stroma component. We observed differences in the volumes of normal and cancer epithelium and stroma within both the J-A and NJ study populations (Po0.01). Only the individual average cancer epithelium (CE) volume (JA ¼ 24.1 vs NJ ¼ 29.9) differed significantly between the NJ and J-A study populations (P ¼ 0.03). Consequently, the S-E ratio in NJ group was significantly different from that of J-A population (P ¼ 0.05). The decrease in S-E ratio noted in the malignant tissues of NJ prostate tissue may provide a biological marker for differentiation of the two groups and suggests a need for further investigations into the molecular basis for these histologic differences.
Introduction
Prostate cancer (PCa) is the most common malignancy among men in the United States. The disease accounts for about a third of all US male cancers, 1, 2 and is the second most important cause of cancer-related death. 1, 3, 4 Approximately 30% of men who are treated for localized disease will recur, and a subset of these men will develop progressive disease. [3] [4] [5] One intriguing and controversial aspect of prostate cancer is that despite the similar high incidence of latent forms of prostate cancer detected in men throughout the world, there exists remarkable disparity in the rate of clinical progression of this disease among Eastern and Western cultures. 6, 7 While about 3% of latent cancer diagnosed is expected to progress to clinically significant cancer in American men, 1 the rate of clinical prostate cancer progression among populations living in Japan, Korea and China is only a fraction of that found in the US.
There are several reports of a lower incidence of prostate cancer in the Asian populations, especially in the Japanese and Chinese. [6] [7] [8] [9] [10] According to Fukagai et al, 11 the incidence of clinical prostate cancer among Japanese-Americans (J-A) is intermediate between Japanese living in Japan and Caucasians in the United States. More recent epidemiologic data indicate that an increasing incidence of clinical prostate cancer has been found in the Japanese and Chinese populations living in the United States and Canada. 6, [10] [11] [12] [13] These comparative analyses between the same ethnic groups living in different parts of the world were conducted in an attempt to determine the role of lifestyle and environmentally related factors in the etiology of prostate cancer. 14 Prostate adenocarcinomas are epithelial tumors and there is compelling evidence to support the concept of a reactive stromal response to insult (trauma, infection, inflammation, etc), which may contribute to prostate cancer recurrence and progression. Several factors have been identified to be associated with PCa growth, development and progression such as endocrine status, age, stromal-epithelial interactions, and genetic background of the host. 6, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] One important biological variable is stromal-epithelial interaction, a potential environmentally responsive host factor that may play a key critical role in determining the rate of prostate cancer initiation, growth and progression. [16] [17] [18] [19] [20] [21] Recently, the concept of a broader role for a reactive stroma in PCa pathogenesis was introduced to describe a genesis of a modified stromal microenvironment created in response to PCa that accompanies biochemical recurrence and tumor progression. [19] [20] [21] Despite several epidemiological studies suggesting a difference in the cancer incidence rates of clinical progression of the disease between native Japanese (NJ) and J-A, not much has been done to examine possible histological differences between these two groups. Based upon the published differences in the incidence and pathology of PCa in JA vs NJ populations and a developing literature on the importance of stromaepithelial interaction in Pca, we believed there might be a difference in these tissue components in the two test populations. Therefore, we examined the stromalepithelial volumes and ratios in PCa, and associated normal tissue to explore a possible histogenic basis to help explain the different incidence rates of the disease and clinical progression in NJ vs J-A populations. We performed specific epithelial immunohistochemical and Masson trichrome histochemical staining on a tissue microarray prepared from radical prostatectomy specimens of 25 NJ and 25 J-A who have undergone radical prostatectomy for prostate cancer.
Materials and methods

Patient sample
A retrospective study was performed on 50 men undergoing radical prostatectomy for cure of localized PCa during the period of 1994-2001. Each participant signed a consent form approved by both the UCLA and the Nagoya Urology Hospital IRBs, and each man completed clinical and dietary questionnaires, donated blood and urine samples and underwent measurement of height, weight, and a bioimpedance test for body fat determination. All men had typical Japanese surnames and regarded themselves as of pure Japanese decent. In total, 25 men were Japanese born men undergoing their operation in Nagoya, Japan, and 25 were second-or third-generation American-born Japanese men undergoing the operation in Los Angeles, CA (USA). Excluded were men that had any form of androgen therapy or preoperative irradiation. All men were interviewed postoperatively between April and October 2001 and their PSA levels were p0.4 ng/ml and had no clinical evidence of cancer. All specimens and questionnaires were processed through the offices of the Urological Sciences Research Foundation in Culver City, CA.
Tissue preparations
The tissue microarrays (TMA) were prepared by the Johns Hopkins University School of Medicine Prostate Special Programs of Research Excellence (SPORE) Grant Pathology Core facility (Dr Angelo De Marzo, PI). The normal-appearing and malignant regions of all men's radical prostate tissue were identified by a pathologist; four 2.0 mm cores were extracted from both areas and placed into master blocks. The tissue microarray was prepared using a Beecher MT1 manual arrayer (Beecher Instruments, Silver Spring, MD, USA) each TMA was constructed using the four replicate 2.0 mm core tissue samples from the normal-appearing and cancer areas of each patient who had undergone radical prostatectomy for PCa. Each block had an orientation marker and contained internal controls placed in a pre-established pattern throughout each one of the blocks to assess quality of the histochemical and immunochemical stains throughout the sections. Slides prepared from each of the TMA blocks were stained with H&E and the normalappearing and cancer areas for each patient's core set were reviewed by a single pathologist to ensure their diagnostic accuracy. The antigenic integrity of the TMA cores was established using Immunohistochemical staining with p27 antibody (Transduction Laboratories, Newington, NH, USA) using the DAKO Envision kit (Carpentaria, CA, USA).
Histological measurements
This stromal-epithelial image analysis technique to identify and measure the three major prostate tissue components was modified from reported by Shapiro et al. 23 Adjacent TMA sections were stained with an anticytokeratin antibody CAM 5.2 obtained from Becton Dickinson Catalog No. 349205 (San Diego, CA, USA) and the Masson trichrome stain for collagenous stromal structures stain blue and smooth muscle stains red. 25, 26 The immunohistochemical (IHC) staining employed CAM 5.2 monoclonal antibody and the DAKO LSAB 2 System, Catalog No. K0675 (Carpentaria, CA, USA), which uses DAKO HRP-DAB Substrate-chromogen System that is specific for epithelium and yields a brown color and the Luminal area remains unstained by both Stromal-epithelial ratios in prostate cancer RW Veltri et al stains and hence appears as white space. 27 Figure 1a , b illustrates only one image each of histochemical staining of cancer and normal tissue spots. The immunohistochemical (IHC) staining employed CAM 5.2 monoclonal antibody and the DAKO LSAB 2 System, Catalog No. K0675 (Carpentaria, CA, USA), which uses DAKO HRP-DAB Substrate-Chromogen System that is specific for epithelium and yields a brown color and the Luminal area remains unstained by both stains and hence appears as white space (see Figure 1c , d). Histological sections were viewed at Â 400 magnification with a highresolution color video camera (Pulnix, Inc.) connected to an upright BHT Olympus microscope. TMAs consisting of four replicate 2.0 mm tissue spots from the cancer and benign areas of 25 NJ and 25 J-A prostate glands removed at radical prostatectomy were prepared. For each patient, the percent stroma, percent epithelium, and the stromal/epithelial ratio were determined separately from each 2.0 mm tissue spot from the benign and cancer areas. The latter were then averaged separately for each patient, and these average values were used in all subsequent statistical analyses. We captured five representative fields of view (FOV) from the four TMA 2 mm spots (about 20 FOV per case). Images were digitized with a Data Translation DT-2871 frame grabber and image processing board using a personal computer. Color image analysis quantitation was performed with image analysis software programs written in C þ þ language and previously applied for analysis of histologic sections of anatomic benign prostatic hypertrophy (BPH). 24, 25 The percent stroma was calculated by subtracting the CAM 5.2 IHC-stained epithelium area (brown) from the blue (collagen and extracellular matrix components) and red (smooth muscle) of the Masson trichrome-stained areas. Stroma-to-epithelial ratio was calculated for each field by dividing percent stroma by percent epithelium.
Statistical analysis
The average stroma-epithelial volumes and ratio measurements were tested for a normal distribution, and only the stromal/epithelial ratios were non-normally distributed. The ratios for both the normal and cancer areas were transformed using the natural log function, which resulted in a normal distribution. The transformed ratio values were used in all subsequent statistical analyses. The percent stroma, percent epithelium, and the transformed stromal/epithelial ratios from the benign and cancers areas were then compared within and between the NJ and J-A patient groups. Parametric paired t-testing was used to test for differences between the measurements within each of the two patient groups (ie J-A vs J-A or NJ vs NJ), and unpaired t-testing was utilized to test for differences in the measurements between the two patient groups (ie J-A vs NJ). Table 1 presents the patient cohort demographics and a statistically significant difference in age, weight, and total body fat of the two groups; all other variables were not distinguishable. There were 17 organ confined (pT2) tumors in the J-A group and 21 in the NJ group, but this difference was not statistically significant (P ¼ 0.17), nor did the Gleason scores differ significantly (P ¼ 0.15). Table 2 summarizes the mean percent stroma and epithelium volumes as well as the stromal-epithelial ratio measurements for the two groups. Notably, the epithelial tissue component showed marked differences in volume between both the normal and cancer areas within the two groups as expected. Also the cancer epithelial (CE) volume as well as the stromal-epithelial ratio differed significantly between J-A and NJ test groups (P ¼ 0.05). To further emphasize these differences, Figure 2 illustrates the important stromal-epithelial ratio comparisons for both the normal and cancer areas and demonstrates the significant difference observed for the stromal-epithelial ratios in the cancer areas between the JA and NJ test groups. Table 3 Stromal-epithelial ratios in prostate cancer RW Veltri et al component volumes as well as the ratios using t-tests.
Results
Only the statistically significantly different t-test comparisons are highlighted. As expected, there are quite significant differences between normal and cancer epithelium (CE) tissue volumes within each of the two test groups. The most clinically relevant t-test cancer epithelial volume observation is that comparing the JA-CE vs the NJ-CE, which differed significantly (P ¼ 0.03) even though these two patient samples did not differ significantly as it relates to stage and grade of the cancers. The latter observation on CE relates directly to our analysis of the Natural Log transformed data comparing S-E ratios for JA-CR to the NJ-CR, which also was significantly different (P ¼ 0.05). Also as expected, for comparisons of the normal ratio (NR) vs cancer ratio (CR) within and between test groups; JA-NR vs NJ-CR (P ¼ 0.0005) and NJ-NR vs NJ-CR (P ¼ 0.03), the results were significantly different.
Discussion
Normal prostatic development from the embryonic urogenital sinus requires epithelial-mesenchymal interactions and is highly dependent on action of androgens as well as estrogens on their receptors for growth and maturation. [15] [16] [17] [18] [19] 23 Once mature, the stromal compartment is essential not only for structural support of the secretory epithelium and basal cell compartment but also for wound repair and is critical to sustaining the normal functions of the secretory epithelium and its underlying basal cell layer. 16, 19 The stroma is a complex of stromal cells and the extracellular matrix, fibroblasts, muscle cells, blood vessels (endothelial cells), a variety immune cells and nerves. There are a myriad of growth factors, numerous regulatory molecules, cytokines, and remodeling enzymes present in the prostate as well. 24 These structural tissue components and their associated autocrine and paracrine soluble factors not only sustain normal physiologic homeostasis but also become involved in the etiology and pathogenesis of both benign and malignant growth processes in the prostate. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] There are several classes of therapeutic drugs used to treat benign and malignant prostate diseases that target stroma and epithelium tissue compartments. For example, lower urinary tract symptoms can be controlled rapidly by a direct action on a stromal tissue component, through blocking of the alpha adrenergic receptors (eg terazosin, doxazosin and tamsilosin). 28 Alternatively, there are drugs that block a5-reductase (Finasteride) and reduce the conversion of dihydrotestosterone to the more active testosterone molecule and are effective in the treatment of benign prostatic hypertrophy (BPH) and specifically its impact on epithelial volume. 27, 28 The role of aromatase and the interaction of estrogens with the stroma and epithelial components of the prostate may also be important in both benign and malignant processes. 23 In the case of PCa, it appears that although ultimately ineffective due to androgen-independent growth of the cancer, complete androgen ablation by either surgical or chemotherapeutic means for advanced PCa is currently only a palliative treatment. 24 From an epidemiologic perspective, the incidence rates of prostate cancer among different races are well documented and have demonstrated significant differences. [5] [6] [7] [8] [9] [10] [11] [12] [13] While African-Americans demonstrate the highest incidence, Asians show relatively lower rates of the PCa. 5, 6, 13 One particular ethnic population-the Japanese-Americans (J-A)-have been studied more than others in an attempt to go one step closer in unraveling the etiology of cancer. Several studies revealed the incidence rate of prostate cancer among J-A is higher than that of the age-matched NJ group living in Japan. 1, 6, 7, [11] [12] [13] [14] Despite these studies, there is a continuing debate whether this noted difference is due to less aggressive screening and lower public awareness of the disease in Japan. However, in order to estimate undetected prostate cancer in the two populations, Shibata et al 12 looked at age-specific PSA in community-based samples of men without the cancer, and suggested that though somewhat exaggerated, the incidence rate among J-A is indeed higher than NJ. If the two populations with the same genetic background respond differently to PCa development, then it demands more explanation than solely a genetic influence.
Hence, the above discrepant observations serve as a potential basis for consideration of environmental (change in diet, lifestyle, etc.) and an epigenetic influence N.S. P = < 0.03 Figure 2 Mean stromal-epithellal ratio.
Stromal-epithelial ratios in prostate cancer RW Veltri et al on cancer development and its progression in the host. Numerous pathologic (infections and chronic inflammation) molecular events (deletions, mutations, amplifications, methylation, etc) have been identified to be critical in early PCa and its precursor lesions (high-grade PIN and prostatic inflammatory atrophy) and also may be key to determining risk for progression of the disease. 14, 21, 24, [29] [30] [31] [32] Additional evidence in PCa that the total tissue microenvironment dynamics may contribute to explaining differences between J-A and NJ comes from recent reports that stress the importance of stromaepithelial interaction in biochemical recurrence and PCa progression. [18] [19] [20] [21] [22] In our study, we examined both normal-appearing adjacent and malignant histological areas of the malignant prostate between J-A and NJ by measuring the percent stroma and epithelium volumes and stromalepithelial ratios. The objective was to investigate any histogenic differences in the response to PCa at the tissue level between the two Japanese groups using a trichrome histochemical stain that identifies collagenous stromal areas as blue structures and smooth muscle stains red, while the IHC-specific CAM 5.2 antibody for cytokeratin stains epithelium dark brown. This unique combination of stains permits, through the use of a unique software program, our observation of any histological differences in stromal-epithelial ratio between the J-A and NJ cancer areas. Our data clearly showed that despite the similarities in pre-op PSA, pathologic stage and Gleason score, there was a lower cancer epithelial volume and stromalepithelial ratio in the malignant region of the NJ prostate samples when compared to the J-A group (P ¼ 0.03). Our results may provide one important clue as well as a target to assess the possible molecular mechanisms that influence stromal-epithelial interactions. Additional evidence in support for a molecular basis to explain the biology of differences between the JA and NJ test groups comes from Dr Leonard Marks, 33 one of the study coordinators, who presented preliminary results on several biomarkers and nuclear morphometry at the AUA in 2003. Dr. Marks reported that 5 0 -lipoxygenase and caspase-3 were differentially up-regulated in the NJ and JA groups and also that alterations in nuclear structure and chromatin of the epithelial cells in the cancer areas accurately separated the JA and NJ test groups.
We believe this to be the first report using the stromalepithelial ratio in PCa to identify histological differences within the same race residing in different parts of the world.
The stromal tissue compartment is known to play an important role in tumor growth as well as PCa progression. [15] [16] [17] [18] [19] [20] [21] [22] The stroma is not just an inert scaffold supporting the epithelial neoplasm, but instead plays a highly active and dynamic essential role in PCa tumorigenesis and progression. Chung 18 proposed that tumorigenic fibroblasts induced epithelial proliferation and organization to form adenocarcinoma through cellcell interaction, and demonstrated that fibroblasts enhance tumorigenesis in rat and human prostate carcinoma cells. Hayward et al 15, 21 proposed a hypothesis that a sequential disruption in reciprocal homeostatic interactions between the epithelium and the smooth muscle results in loss of both morphogenic and homeostatic signaling between the emerging prostatic carcinoma cells and local smooth muscle cells. Both of these authors have subsequently validated and extended these observations as to the importance of these stromal cellular components in prostate cancer progression and metastasis. 19, 22 Also, more recent sizable retrospective studies of the stromal-epithelial compartments in PCa seem to support this working hypothesis of a key role for a reactive stroma in clinical progression of PCa. 20, 21 Hence, smooth muscle is observed to progressively diminish around human prostatic adenocarcinomas during progression from low to high grade cancers. According to the reactive stroma hypothesis, the myofibroblastic characteristic, which can be identified using smooth muscle a-actin biomarker, is the most common marker of reactive stroma in PCa. [16] [17] [18] [19] [20] [21] [22] These studies provide important evidence that the stromal compartment's response during carcinogenesis has a significant influence upon associated tumor epithelium through a continual and dynamic phenotypic/genotype switching cycle, which creates a microenvironment favorable to cancer progression. 15, 16, [19] [20] [21] [22] Clearly, future stromal-epithelial studies of the type we have described for the J-A and NJ groups, need to assess additional specific prostate myofibroblastsmooth muscle differentiation biomarkers (eg vimentin, a-actin, calponin, smooth muscle myosin heavy chain, myosin VI, etc) 20 to detect the molecular basis of stromal differences between the two groups.
In addition to the above approach, perhaps a more thorough analysis of the potential role of diet-based micronutrient-gene interactions, 13, 14 which may influence stromal-epithelial tissue phenotypic/genotypic Stromal-epithelial ratios in prostate cancer RW Veltri et al dynamics in PCa, is also needed to help clarify the origin of our observations. The application of gene expression profiling to this problem could prove highly informative given the success that this approach has enjoyed for identifying important molecular signatures relating to biochemical recurrence, progression and metastasis of PCa. 34 Finally, though our study demonstrated a statistically significant difference in the stromal-epithelial ratios among J-A and NJ, it has some limitations. In order to strengthen the clinical relevance of our observations, our study requires repetition using a larger patient cohort that is both age and pathology (degree of inflammation, grade and stage) optimized.
